mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.06 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.07 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.07 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.07 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.08 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.08 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.08 |
mRNA |
R428 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.08 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.08 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.09 |